English press releases

Merck Launches Single-Use Reactor Designed to Accelerate Antibody Drug Conjugate Manufacturing

First scalable single-use mixer specifically designed for ADC manufacturing Increases efficiency by 70% compared to stainless steel or glass manufacturing methods Utilizes Ultimus® Film for...

Quickline enhances rural connectivity across Yorkshire and Lincolnshire with Adtran Mosaic CP

News summary: UK-based service provider required flexible broadband access platform to bridge the digital divide in underserved communities Adtran XGS-PON technology enables Quickline to scale...

Sofinnova Partners appoints Karl Naegler as Partner

Seasoned investor with 20 years of experience and a strong track record strengthens VC’s leadership in early-stage life science investments PARIS–(BUSINESS WIRE)– Sofinnova Partners (“Sofinnova”),...

MRM Health Appoints Grégoire Franoux as Chief Business Officer and Adds Ron Robison to its Board of Directors

GHENT, Belgium–(BUSINESS WIRE)– MRM Health NV, a clinical-stage biopharmaceutical company developing innovative therapeutics for inflammatory, CNS and metabolic diseases, today announced the appointment of Grégoire...

4P-Pharma Welcomes Marina Vasiliou, Christian Bechon, and Alain Sainsot as Independent Members of Its Board

Marina Vasiliou, Biogen France President and Managing Director Christian Bechon, Senior Partner chez Isalys Augmented Management Alain Sainsot, GTP Bioways founder and President LILLE, France...

Adtran sets new SBTi targets for net-zero emissions

News summary: Adtran has committed to new SBTi-approved targets, supporting global 1.5°C climate goals Company roadmap aims for net-zero emissions by 2048 across its entire...

First Patients Dosed in Debiopharm’s Phase III Trial (LIBELULA) Investigating Debio 4326, a 12-Month Triptorelin Formulation for Children with Central Precocious Puberty

Debiopharm’s expertise in extended-release formulations could lighten the burden of treatment for children with Central Precocious Puberty (CPP) and their families by reducing injection frequency...

New KPMG Report Shows Illicit Cigarette Consumption Still at Worrying Levels in the European Union, With Organized Crime Moving Operations Closer to Western Countries

More than 35 billion illicit cigarettes were consumed across the 27 EU member states in 2023, close to 2022 figures. France continues to be the...

Bentley Systems Acquires 3D Geospatial Company Cesium

Combination of Cesium plus iTwin offers developers the most comprehensive digital platform for the built and natural environment EXTON, Pa.–(BUSINESS WIRE)– Bentley Systems, Incorporated (Nasdaq:...

Digital Payments Become Trending Payment Method for Global Merchants Operating in SEA, Ant International’s Antom Insights Show

SHANGHAI–(BUSINESS WIRE)– Digital payments have become the preferred payment method among shoppers in Southeast Asia when they purchase on global online platforms, Antom revealed today...

SES Successfully Prices EUR 1 Billion Hybrid Dual-tranche Bond Offering

LUXEMBOURG–(BUSINESS WIRE)– NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS, ANY STATE...

MYbank Launches AI-Enabled System for SME Money Management at Shanghai’s INCLUSION Conference

SHANGHAI–(BUSINESS WIRE)– MYbank, a leading digital bank in China and an associate of Ant Group, today introduced its AI-enabled system (Cuckoo System) for small and...

Ant Group Unveils AI Financial Manager at Shanghai’s INCLUSION Conference

SHANGHAI–(BUSINESS WIRE)– Ant Group today unveiled its AI financial manager, Maxiaocai, at the 2024 INCLUSION·Conference on the Bund in Shanghai. The AI personal financial manager...

BenevolentAI Notice of Interim Results

LONDON–(BUSINESS WIRE)– BenevolentAI (“BenevolentAI” or the “Company”) (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, will announce its interim...

Novotech Releases 2024 Report on Pancreatic Cancer Clinical Trials and Drug Development

BOSTON–(BUSINESS WIRE)– Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics...